NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

PULMONARY MANIFESTATIONS OF CASTLEMAN'S DISEASE (CD) IN PATIENTS WITH HIV INFECTION.

Guihot A, Boulanger E, Galicier L, Zucman D, Rivaud E, Scherrer A, Agbalika F, Couderc LJ, Oksenhendler E; IAS Conference on HIV Pathogenesis and Treatment (2nd : 2003 : Paris, France).

Antivir Ther. 2003; 8 (Suppl.1): abstract no. 934.

Hopital Foch, Suresnes, France

Aim: To describe the pulmonary manifestations occuring in HIV-infected patients suffering from multicentric CD. METHODS: A retrospective study of the records of 11 patients with pulmonary symptoms out of a total of 66 patients with CD seen between 1990 and the end of 2001. RESULTS: Nine male and two female patients with a mean age of 45 yrs. Ethnic origin: Caucasian 8, African 3. None were IVDA; five males were homosexual. Previous AIDS-related infections: 5/11 cases. Previous Kaposi's sarcoma: five patients. Mean CD4 cell count: 273/mm3 and mean HIV viral load 3.4 log copies. All patients complained of general symptoms: fever 11/11 cases, malaise 10, weight loss 6. Most patients (10/11) exhibited peripheral lymphadenopathy (10), liver (10) or spleen (9) enlargement. The diagnosis of CD was previously performed in 10/11 patients by lymph-node biopsies in all cases. Pulmonary manifestations: interstitial pneumonitis 10 cases, with pleural effusion in two cases, and small mediastinal lymphadenopathies in five cases. One patient (without previous known diagnosis of CD) had a solitary pulmonary nodular opacity. The CD in this case was diagnosed by open-lung biopsy. Fiberoptic endoscopy was normal in all 10 cases. All microbi-ological tests remained negative. Clinical course and follow-up: Chemotherapies in eight patients (mainly etoposide and vinblastine); corticosteroids: four patients, anti-interleukin-6 antibody, one case, thalidomide, one case. The evolution was mainly characterized by 1$#176;) a dramatic improvement in less than 24 hours of the interstitial pneu-monitis, 2$#176;) a high frequency of relapse (38 attacks in the 10 patients with interstitial pneumonitis), 3$#176;) an association of the presence of the clinical attacks with a high HHV-8 viral load, 4$#176;) a high frequency of non Hodgkin's lymphoma (5 out of 11 patients) and haemophago-cytic syndrome (3 cases), 5$#176;) a poor prognosis: five deaths (of lymphoma in four cases). CONCLUSION: HIV-infected patients with CD have 1$#176;) a high frequency of pulmonary manifestations, mainly an acute febrile interstitial pneumonitis with frequent recurrence, 2$#176;) a good response to etoposide and 3$#176;) a poor prognosis related to the development of lymphoma.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Acquired Immunodeficiency Syndrome
  • Biopsy
  • CD4 Lymphocyte Count
  • Female
  • Giant Lymph Node Hyperplasia
  • HIV Infections
  • HIV Seropositivity
  • Humans
  • Lung Neoplasms
  • Lymphoma, Non-Hodgkin
  • Male
  • Retrospective Studies
  • Sarcoma, Kaposi
Other ID:
  • GWAIDS0023588
UI: 102263212

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov